[8-K] PARKERVISION INC Reports Material Event
ParkerVision, Inc. entered into a subscription agreement for 4,761,905 shares of its common stock with director Lewis H. Titterton, Jr. for a total of $1,000,000. The shares are priced at $0.21 per share, matching the last reported sale price of the stock on the OTCQB Venture Market on November 14, 2025. The transaction is being conducted directly by the company without an underwriter, under an existing Form S-3 shelf registration. Because the buyer is a board member, the deal was reviewed and approved by disinterested directors under Florida corporate law, with closing expected on or before November 18, 2025.
- None.
- None.
Insights
ParkerVision raises $1M via an at-market registered share sale to a director.
ParkerVision is raising
The sole investor is director Lewis H. Titterton, Jr., which indicates insider participation in the financing. Because the investor sits on the board, disinterested directors reviewed and approved the transaction in line with Section 607.0832 of the Florida Business Corporation Act, and a legal opinion from Graubard Miller addresses the validity of the issued securities.
The share issuance provides additional equity capital but also adds to the share count, which can dilute existing holders. Closing is expected on or prior to
FAQ
What did ParkerVision (PRKR) announce in this 8-K filing?
ParkerVision (PRKR) announced that it entered into a subscription agreement with director Lewis H. Titterton, Jr. for the sale of 4,761,905 common shares for an aggregate purchase price of $1,000,000.
At what price is ParkerVision (PRKR) issuing the new shares?
The new common shares are being issued at $0.21 per share, which equals the last reported sale price of ParkerVision’s common stock on the OTCQB Venture Market on
Who is buying the newly issued ParkerVision (PRKR) shares?
The buyer is Lewis H. Titterton, Jr., a director of ParkerVision, under a subscription agreement dated
How is the ParkerVision (PRKR) share offering being conducted?
The offering is being made directly by ParkerVision to the director, without an underwriter or placement agent, and relies on the company’s existing Form S-3 shelf registration statement (Registration No. 333-287427).
When is the ParkerVision (PRKR) financing expected to close?
The closing of the transaction is expected to occur on or prior to November 18, 2025, following the subscription agreement signed on November 14, 2025.
How did ParkerVision handle the conflict of interest with a director as investor?
Because the investor is a board member, the transaction was reviewed and approved by the disinterested members of the board in accordance with Section 607.0832 of the Florida Business Corporation Act.
What exhibits were filed with this ParkerVision (PRKR) 8-K?
The filing includes an opinion of Graubard Miller (Exhibit 5.1), the subscription agreement dated November 14, 2025 (Exhibit 10.1), a consent of Graubard Miller (Exhibit 23.1), and the cover page interactive data file (Exhibit 104).